Serum Alpha1-Globulin as a Novel Prognostic Factor in Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors

Targeted Oncology ◽

10.1007/s11523-019-00625-9 ◽

2019 ◽

Vol 14 (2) ◽

pp. 187-195

Author(s):

Xiang Chen ◽

JiaXi Yao ◽

Li Liu ◽

WenZhong Zheng ◽

XiaoYi Hu ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Prognostic Factor ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitors

Download Full-text

Hypertension as a prognostic factor in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: a systematic review and meta-analysis

BMC Urology ◽

10.1186/s12894-019-0481-5 ◽

2019 ◽

Vol 19 (1) ◽

Author(s):

Yu Liu ◽

Liang Zhou ◽

Yuntian Chen ◽

Banghua Liao ◽

Donghui Ye ◽

...

Keyword(s):

Systematic Review ◽

Renal Cell Carcinoma ◽

Prognostic Factor ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitors ◽

Download Full-text

Can Tyrosine Kinase Inhibitors be Discontinued in Patients with Metastatic Renal Cell Carcinoma and a Complete Response to Treatment? A Multicentre, Retrospective Analysis

European Urology ◽

10.1016/j.eururo.2008.10.021 ◽

2009 ◽

Vol 55 (6) ◽

pp. 1430-1439 ◽

Author(s):

Manfred Johannsen ◽

Anne Flörcken ◽

Axel Bex ◽

Jan Roigas ◽

Marco Cosentino ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Retrospective Analysis ◽

Tyrosine Kinase Inhibitors ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitors ◽

Complete Response ◽

Response To Treatment

Download Full-text

Acquired Hypothyroidism as a Predictive Marker of Outcome in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors: A Literature-Based Meta-Analysis

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2014.10.002 ◽

2015 ◽

Vol 13 (4) ◽

pp. 280-286 ◽

Author(s):

Andreas Nearchou ◽

Antonis Valachis ◽

Pehr Lind ◽

Olof Akre ◽

Per Sandström

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Predictive Marker

Download Full-text

PD57-08 TUMORAL CD8+ T CELLS CORRELATE WITH FAVORABLE OUTCOME IN METASTATIC RENAL CELL CARCINOMA TREATED WITH TYROSINE KINASE INHIBITORS

The Journal of Urology ◽

10.1016/j.juro.2018.02.2652 ◽

2018 ◽

Vol 199 (4S) ◽

Author(s):

Jiajun Wang ◽

Li Liu ◽

Wei Xi ◽

Jiejie Xu ◽

Jianming Guo

Keyword(s):

Renal Cell Carcinoma ◽

T Cells ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Metastatic Renal Cell Carcinoma ◽

Cd8 T Cells ◽

Kinase Inhibitors ◽

Favorable Outcome

Download Full-text

Tumor-infiltrating neutrophils predict therapeutic benefit of tyrosine kinase inhibitors in metastatic renal cell carcinoma

OncoImmunology ◽

10.1080/2162402x.2018.1515611 ◽

2018 ◽

Vol 8 (1) ◽

pp. e1515611

Author(s):

Jiajun Wang ◽

Li Liu ◽

Qi Bai ◽

Chenzhang Ou ◽

Ying Xiong ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitors ◽

Therapeutic Benefit

Download Full-text

Treatable causes of diarrhoea in patients on tyrosine kinase inhibitors for metastatic renal cell carcinoma

Annals of Oncology ◽

10.1093/annonc/mdy469 ◽

2019 ◽

Vol 30 (1) ◽

pp. 150-151

Author(s):

S.V. Lightowlers ◽

B. Greef ◽

T. Eisen ◽

A. Matakidou ◽

K. Fife ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitors

Download Full-text

Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma - What Should We Tell Our Patients?

International Journal of Surgery ◽

10.1016/j.ijsu.2017.08.062 ◽

2017 ◽

Vol 47 ◽

pp. S8

Author(s):

J. Cobley ◽

G. Broadley ◽

F. Khan ◽

K. Harvey ◽

C. Parry ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitors

Download Full-text

CXCR1 expression predicts benefit from tyrosine kinase inhibitors therapy in patients with metastatic renal cell carcinoma

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2017.12.023 ◽

2018 ◽

Vol 36 (5) ◽

pp. 242.e15-242.e21

Author(s):

Xiang Chen ◽

Li Liu ◽

Jiajun Wang ◽

Zhiyuan Lin ◽

Ying Xiong ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitors

Download Full-text

Comparison of nivolumab plus ipilimumab with tyrosine kinase inhibitors as first-line therapies for metastatic renal-cell carcinoma: a multicenter retrospective study

International Journal of Clinical Oncology ◽

10.1007/s10147-020-01797-5 ◽

2020 ◽

Vol 26 (1) ◽

pp. 154-162

Author(s):

Koichi Kido ◽

Shingo Hatakeyama ◽

Kazuyuki Numakura ◽

Toshikazu Tanaka ◽

Masaaki Oikawa ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Retrospective Study ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitors ◽

Download Full-text

Absence of Significant Correlation of Adverse Events Between First- and Second-Line Tyrosine Kinase Inhibitors in Patients With Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2015.08.002 ◽

2016 ◽

Vol 14 (1) ◽

pp. e19-e24 ◽

Author(s):

Hideaki Miyake ◽

Satoshi Imai ◽

Ken-ichi Harada ◽

Masato Fujisawa

Keyword(s):

Renal Cell Carcinoma ◽

Adverse Events ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Tyrosine Kinase Inhibitors ◽

Metastatic Renal Cell Carcinoma ◽

Kinase Inhibitors ◽

Download Full-text